Total Payments
$4,307
2024 Payments
$723.54
Companies
52
Transactions
185
Medicare Patients
8,725
Medicare Billing
$808,919
Payment Breakdown by Category
Food & Beverage$3,998 (92.8%)
Gifts$201.39 (4.7%)
Education$108.00 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,998 | 181 | 92.8% |
| Gift | $201.39 | 1 | 4.7% |
| Education | $108.00 | 3 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $370.14 | 12 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $315.09 | 3 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $279.07 | 4 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $277.60 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $273.44 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $260.44 | 12 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $214.48 | 11 | $0 (2024) |
| NxThera, Inc. | $201.39 | 1 | $0 (2017) |
| 180 Medical, Inc. | $201.19 | 9 | $0 (2024) |
| Telix Pharmaceuticals | $126.19 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $723.54 | 38 | ABBVIE INC. ($176.83) |
| 2023 | $927.23 | 42 | Sumitomo Pharma America, Inc. ($155.84) |
| 2022 | $846.18 | 39 | Janssen Biotech, Inc. ($165.25) |
| 2021 | $351.37 | 17 | Astellas Pharma US Inc ($98.38) |
| 2020 | $79.23 | 5 | 180 Medical, Inc. ($28.08) |
| 2019 | $193.53 | 11 | Janssen Biotech, Inc. ($43.02) |
| 2018 | $165.19 | 10 | SeaPearl Inc ($34.63) |
| 2017 | $1,021 | 23 | Dendreon Pharmaceuticals LLC ($249.70) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: UROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/09/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Cook Medical LLC | COOK (Device) | Food and Beverage | Cash or cash equivalent | $18.77 | General |
| Category: Urology | ||||||
| 08/26/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/23/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diagnostic Imaging | ||||||
| 08/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Oncology | ||||||
| 08/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: AMS 700_URO | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Oncology | ||||||
| 07/12/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/08/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Oncology | ||||||
| 06/07/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 05/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: UROLOGY | ||||||
| 05/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,070 | 3,142 | $852,660 | $191,713 |
| 2022 | 23 | 2,154 | 3,066 | $952,036 | $195,992 |
| 2021 | 20 | 2,241 | 3,244 | $879,833 | $232,370 |
| 2020 | 25 | 2,260 | 3,089 | $812,150 | $188,845 |
Total Patients
8,725
Total Services
12,541
Medicare Billing
$808,919
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 547 | 968 | $407,418 | $98,733 | 24.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 90 | 100 | $81,656 | $20,617 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 218 | $65,406 | $16,629 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $46,126 | $10,848 | 23.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 72 | $38,657 | $9,700 | 25.1% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 13 | 16 | $46,956 | $7,872 | 16.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 334 | 502 | $25,620 | $4,730 | 18.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $17,017 | $4,272 | 25.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 28 | 30 | $12,313 | $2,834 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $10,927 | $2,819 | 25.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 26 | 26 | $26,248 | $2,802 | 10.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 25 | 50 | $11,624 | $2,742 | 23.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 562 | 900 | $6,075 | $1,965 | 32.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 28 | $5,336 | $1,347 | 25.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $4,187 | $1,017 | 24.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 12 | $24,918 | $973.62 | 3.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 27 | 27 | $14,319 | $741.15 | 5.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 23 | $2,734 | $714.61 | 26.1% |
| 76000 | Imaging guidance for procedure, 60 minutes or less | Facility | 2023 | 18 | 27 | $5,122 | $358.02 | 7.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 598 | 998 | $363,943 | $103,005 | 28.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 95 | 110 | $72,383 | $24,789 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 106 | 106 | $58,358 | $14,664 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 154 | $38,424 | $11,996 | 31.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2022 | 11 | 17 | $98,266 | $8,497 | 8.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 75 | $32,067 | $6,558 | 20.5% |
About Dr. Vincent Cubelli, M.D
Dr. Vincent Cubelli, M.D is a Urology healthcare provider based in Denville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053353474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Cubelli, M.D has received a total of $4,307 in payments from pharmaceutical and medical device companies, with $723.54 received in 2024. These payments were reported across 185 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($3,998).
As a Medicare-enrolled provider, Cubelli has provided services to 8,725 Medicare beneficiaries, totaling 12,541 services with total Medicare billing of $808,919. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Denville, NJ
- Active Since 06/11/2006
- Last Updated 06/15/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1053353474
Products in Payments
- GEMTESA (Drug) $356.55
- PROVENGE (Drug) $325.97
- AQUABEAM ROBOTIC SYSTEM (Device) $315.09
- ERLEADA (Drug) $216.17
- BOTOX (Biological) $207.34
- Rezum (Device) $201.39
- Androgel (Drug) $175.99
- XTANDI (Drug) $142.02
- ILLUCCIX (Drug) $126.19
- Myrbetriq (Drug) $119.86
- LYNPARZA (Drug) $114.21
- PYLARIFY (Drug) $113.97
- DARZALEX (Biological) $112.21
- PROLARIS (Device) $109.57
- Prolaris (Device) $89.37
- Nubeqa (Drug) $86.90
- JELMYTO (Drug) $79.14
- ORGOVYX (Drug) $76.22
- Prolia (Biological) $69.41
- JATENZO (Drug) $61.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Denville
Michael Ingber, M.d, M.D
Urology — Payments: $598,659
Urology $598,659
Alan Strumeyer, M.d, M.D
Urology — Payments: $15,878
Urology $15,878
Gregg Zimmerman, Md, MD
Urology — Payments: $9,640
Urology $9,640
Dr. Alexander Gellman, M.d, M.D
Urology — Payments: $1,345
Urology $1,345
Dr. David Dershewitz, M.d, M.D
Urology
Urology